Thursday, November 15, 2012

InvestorsGuru.com Breakout Small-Caps: DANG E-Commerce China Dangdang, CEL Cellcom Israel, ACRX AcelRx Pharma, MEIP MEI Pharma, TCX Tucows, MEET MeetMe, MJNA Medical Marijuana, tsx/v: PTA Petroamerica Oil

Guru Trader Tweet of 8 Notable Market Movers - High Volume, Price Action & News:

NYSE:
DANG E-Commerce China Dangdang $4.16 +$0.48 2.7m - %G,
CEL Cellcom Israel Ltd $8.86 +$0.31 .6m - %G,

NASDAQ:
ACRX AcelRx Pharmaceuticals $3.36 +$0.16 1.7m - %G|YH,
MEIP MEI Pharma Inc $1.63 +$0.05 .6m - %YH,

AMEX:
TCX Tucows Inc $1.38 -$0.01 .1m, FT@ $0.84
MEET MeetMe Inc $2.65 +$0.41 .4m - %G|$G,

OTC:
MJNA Medical Marijuana Inc $0.125 +$0.01 23m - VA,

TSXV:
PTA Petroamerica Oil Corp $0.265 -$0.005 4.2m - VA,

Top 10: VA Volume Active, %G Percent Gainer or $G Dollar Gainer. YH 52-Week High, NH 10-Year New High, FT@ First Tweeted at price (within a year +/-) - verify or follow live at twitter.com/InvestorsGuru or subscribe to blog.InvestorsGuru.com

Recent News Headlines

- Nov 15, (NYSE: DANG) Dangdang Announces Third Quarter 2012 Results (Year-Over-Year Q3 Revenues: Net +42%, Media +33%, General Merchandise +56%)
- Nov 13, (NYSE: CEL) Cellcom Israel Announces Third Quarter 2012 Results (free cash flow +58%, continues efficiency plan, nets 5,000 new cellular subscribers)
- Nov 11, (NYSE: CEL) Cellcom Israel Announces Update Regarding Purported Class Action Pending Against the Company
- Nov 15, (NASDAQ: ACRX) AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain (conference call and webcast today to discuss top-line results)
- Nov 06, (NASDAQ: ACRX) AcelRx Pharmaceuticals Reports Q3 2012 Financial Results
- Nov 06, (NASDAQ: MEIP) MEI Pharma Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome (Data Accepted for Presentation at American Society of Hematology Annual Meeting on Dec 10)
- Nov 05, (NASDAQ: MEIP) MEI Pharma Announces $27.5M Private Placement Financing Led by New Institutional Investors Vivo Ventures and New Leaf Venture Partners
- Nov 15, (AMEX: MEET) MeetMe Inc. Ranked Number 32 Fastest Growing Company in North America on Deloitte’s 2012 Technology Fast 500
- Nov 07, (AMEX: MEET) MeetMe Inc. Reports Financial Results for Q3 of 2012
- Nov 13, (AMEX: TCX) Tucows Plans to Commence Dutch Auction Tender Offer
- Nov 13, (TSX: TC) Tucows Reports Continuing Strong Financial Results for Q3 2012
- Nov 15, (OTC: MJNA) Medical Marijuana Portfolio Company CanChew BioTechnologies Inc. Announces Final Day for Market Survey and Free Product Trial Registration
- Nov 15, (OTC: MJNA) Medical Marijuana Inc. Reports Third Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1500% From Same Period Last Year
- Nov 7, (OTCPK: MJNA) Medical Marijuana Inc. Sees Growth Opportunities For Its Portfolio Company with Historic Washington 502 Vote to Legalize Marijuana for Recreational Use, Massachusetts New Medical Marijuana Initiative and Michigan Vote to Decriminalize Marijuana in Four Major Cities
- Nov 7, (PINKSHEETS: MJNA) Medical Marijuana Inc. Anticipates Increased Opportunities For Its Portfolio Company with Colorado Voters Passage of Amendment 64, Becoming First State to Legalize Marijuana for Recreational Use
- Nov 13, (TSXV: PTA) Petroamerica Announces Light Oil Discovery at La Casona-1 and Provides an Operations Update for its Colombian Activities

We filter today's market movers, then focus on 5 or more small-cap stocks with seemingly positive news and/or technical chart momentum, while excluding one-day-only events such as a buyout. Click symbols above, or Submit any symbol to our Detailed Quote Portal at InvestorsGuru.com, for its stock quote, chart, news, research and to view/post/share comments at any ticker's bulletin board. Sign-up for our Small Cap Stock Observer Newsletter, Featured Stock Profiles & News by Email, and to setup your own My Portfolio, My Watchlist & Alerts and email preferences. Free!

1 comment:

  1. I must say this is a best blog post. I have read your last two blog posts on the similar topic, those were wonderful too. Keep it up and keep posting blogs on related matter.

    ReplyDelete